SingleC-9 Binding Agents
The present invention relates to agents capable of binding sialic acid-binding immunoglobulin-like lectin-9 (Siglec-9) and their use in the treatment of cell proliferation and differentiation disorders. Furthermore, the present invention provides associated pharmaceutical formulations and methods.
Patents:US 20,110,104,149 [
MORE INFO]
Inventor(s):
CROCKER PAUL RICHARD [GB]; BIEDERMANN BJOERN [GB]; BOWEN DAVID [GB]
Type of Offer:
Sale
« More Pharmaceutical Patents